Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene Expression Signature–Based Prognostic Risk Score in Patients with Primary Central Nervous System Lymphoma

20 Aug 2012

Abstract excerpt

PURPOSE: Better understanding of the underlying biology of primary central nervous system lymphomas (PCNSL) is critical for the development of early detection strategies, molecular markers, and new therapeutics. This study aimed to define genes associated with survival of patients with PCNSL. EXPERIMENTAL DESIGN: Expression profiling was conducted on 32 PCNSLs. A gene classifier was developed using the random...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CNS Lymphoma Diagnosis and Treatment
Share to Glioma Diagnosis and Treatment
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22908096
DOI: 10.1158/1078-0432.ccr-12-0596

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene Expression Signature–Based Prognostic Risk Score in Patients with Primary Central Nervous System LymphomaPMID 22908096Read ↗

A novel scoring model (SII-MSKCC) to better predict the clinical outcomes of primary central nervous system lymphomaSemantic proximity Read ↗

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in TreatmentSemantic proximity Read ↗

Insights into the biology of primary central nervous system lymphoma.Semantic proximity Read ↗

Gene expression signature‐based prognostic risk score in patients with glioblastomaSemantic proximity Read ↗

miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphomaSemantic proximity Read ↗

Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma.Semantic proximity Read ↗

A novel nomogram for predicting overall survival in peripheral T cell lymphoma patientsSemantic proximity Read ↗

Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma.Semantic proximity Read ↗

Pathway analysis of primary central nervous system lymphomaSemantic proximity Read ↗

Genomic landscape and molecular subtypes of primary central nervous system lymphoma.Semantic proximity Read ↗

Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma.Semantic proximity Read ↗

Improved Personalized Survival Prediction of Patients With Diffuse Large B-cell Lymphoma Using Gene Expression ProfilingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.